Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -2.71%4.66B | -5.80%3.48B | -4.20%2.1B | -1.08%6.34B | -2.23%4.79B | 2.39%3.69B | 0.93%2.19B | 9.42%6.4B | 11.14%4.9B | 13.60%3.6B |
| Operating revenue | -2.65%4.6B | -5.78%3.43B | -4.11%2.08B | -0.86%6.25B | -2.16%4.72B | 2.48%3.64B | 0.95%2.17B | 9.26%6.3B | 10.96%4.83B | 13.46%3.56B |
| Other operating revenue | ---- | -6.49%30.95M | ---- | -22.35%60.34M | ---- | -35.34%33.1M | ---- | 57.43%77.71M | ---- | 131.18%51.19M |
| Interest income | -6.89%62.87M | -7.49%43.02M | -11.87%21.39M | -14.59%87.47M | -7.05%67.52M | -4.32%46.51M | -0.46%24.27M | 20.40%102.42M | 24.38%72.64M | 24.96%48.61M |
| Total operating cost | -4.74%4.37B | -8.34%3.18B | -3.70%1.97B | -1.29%6.27B | -3.86%4.59B | 1.82%3.47B | -2.51%2.04B | 9.08%6.35B | 11.88%4.77B | 12.58%3.41B |
| Operating cost | -4.80%3.74B | -8.60%2.77B | -3.44%1.8B | -0.49%5.37B | -2.90%3.93B | 2.87%3.03B | 0.60%1.86B | 7.64%5.4B | 10.58%4.05B | 12.97%2.95B |
| Operating tax surcharges | -2.86%17.44M | -4.76%12.27M | -5.86%6.71M | 1.40%24.01M | 3.71%17.95M | 7.15%12.88M | 16.01%7.13M | -6.54%23.68M | 10.04%17.31M | 7.27%12.02M |
| Operating expense | 4.94%189.68M | 7.06%122.25M | 0.11%58.07M | -3.31%196.55M | -2.84%180.75M | -8.84%114.19M | 28.22%58.01M | 1.90%203.29M | 6.04%186.04M | 7.21%125.27M |
| Administration expense | -4.07%301.14M | -14.31%189.15M | -8.66%73.18M | -1.03%511.19M | -18.48%313.93M | -6.14%220.73M | -27.39%80.12M | 32.09%516.51M | 18.71%385.08M | 18.79%235.16M |
| Financial expense | -17.29%118.85M | -4.62%81.15M | -13.48%28.37M | -21.20%162.72M | 6.59%143.7M | 2.44%85.08M | -58.95%32.79M | 9.36%206.5M | 52.41%134.81M | -5.38%83.05M |
| -Interest expense (Financial expense) | -18.65%159.83M | -18.49%107.47M | -18.62%55.71M | -12.44%258.02M | -16.10%196.47M | -18.34%131.85M | -14.01%68.46M | -9.74%294.69M | -4.67%234.17M | -0.48%161.46M |
| -Interest Income (Financial expense) | 14.47%-58M | 14.70%-32.82M | 11.46%-29.57M | -10.99%-74.34M | -14.51%-67.81M | -31.71%-38.48M | -89.14%-33.4M | -145.51%-66.98M | -175.42%-59.22M | -153.17%-29.21M |
| Research and development | 200.00%693.4K | 0.00%231.13K | --231.13K | 2.11%457.55K | -10.91%231.13K | -10.91%231.13K | ---- | 6.74%448.11K | --259.43K | --259.43K |
| Credit Impairment Loss | -120.90%-499.35K | 44.65%-1.13M | 5.29%-2.74M | 94.34%-1.56M | -48.02%2.39M | -191.38%-2.04M | -77.08%-2.89M | 69.23%-27.54M | 249.61%4.6M | 232.61%2.23M |
| Asset Impairment Loss | ---19.99M | ---- | ---- | 87.46%-53.12K | ---- | ---- | ---- | 94.51%-423.46K | ---- | ---- |
| Other net revenue | 148.65%433.45M | 103.10%211.8M | 1,417.38%149.25M | 3.93%360.08M | -38.76%174.32M | -76.41%104.28M | -104.24%-11.33M | 203.66%346.45M | 290.30%284.62M | 350.27%442.08M |
| Fair value change income | -1,082.89%-269.05M | -4,653.06%-237.18M | 327.92%11.87M | 107.18%24.53M | 87.19%-22.74M | 96.74%-4.99M | 86.57%-5.21M | 56.41%-341.48M | 12.95%-177.62M | -42.38%-152.94M |
| Invest income | 328.64%690.37M | 392.73%436.8M | 1,401.75%134.66M | -55.76%292.37M | -63.03%161.06M | -84.66%88.65M | -103.44%-10.34M | 36.27%660.92M | 1,249.46%435.7M | 841.77%577.77M |
| -Including: Investment income associates | 693.54%651.75M | 1,379.49%420.09M | 592.30%122.88M | -49.28%190.43M | -76.87%82.13M | -94.74%28.39M | -108.84%-24.96M | 396.76%375.49M | 827.86%355.04M | 543.94%539.52M |
| Asset deal income | 2,583.61%4.22M | 59.27%-74.44K | -81.69%13.34K | -27.97%11.99M | -142.16%-169.82K | -145.22%-182.76K | 1,352.74%72.82K | -32.66%16.65M | 125.38%402.83K | 125.51%404.17K |
| Other revenue | -15.95%28.4M | -41.40%13.39M | -22.66%5.45M | -14.44%32.8M | 56.85%33.79M | 56.22%22.84M | -3.26%7.04M | 4.37%38.33M | -20.73%21.54M | 19.39%14.62M |
| Operating profit | 92.04%723.27M | 55.88%509.04M | 104.51%282.23M | 6.50%429.06M | -8.61%376.63M | -48.97%326.56M | -59.86%138M | 234.05%402.88M | 6,569.92%412.1M | 2,268.04%639.99M |
| Add:Non operating Income | 54.67%2.49M | 104.65%1.55M | -2.18%668.77K | 851.16%13.37M | -91.14%1.61M | -66.09%759.66K | -45.76%683.67K | -70.77%1.41M | 593.21%18.16M | 168.57%2.24M |
| Less:Non operating expense | 181.83%2.11M | 82.91%1.29M | 49.69%450.02K | 447.47%7.72M | 202.65%749.95K | 271.04%703.38K | 152.57%300.64K | -62.48%1.41M | -65.25%247.79K | 154.68%189.57K |
| Total profit | 91.70%723.64M | 55.94%509.31M | 104.11%282.45M | 7.90%434.71M | -12.21%377.48M | -49.13%326.62M | -59.89%138.38M | 234.52%402.88M | 9,734.82%430.01M | 2,332.44%642.04M |
| Less:Income tax cost | -0.36%97.08M | -15.50%82.93M | -22.46%42.08M | 7.10%106.29M | 56.78%97.43M | 32.18%98.14M | 30.49%54.27M | 318.52%99.24M | 7.34%62.15M | 120.28%74.25M |
| Net profit | 123.73%626.56M | 86.62%426.39M | 185.78%240.36M | 8.16%328.43M | -23.87%280.05M | -59.76%228.48M | -72.28%84.11M | 219.51%303.63M | 689.88%367.86M | 1,008.99%567.79M |
| Net profit from continuing operation | 123.73%626.56M | 86.62%426.39M | 185.78%240.36M | 8.16%328.43M | -23.87%280.05M | -59.76%228.48M | -72.28%84.11M | 219.51%303.63M | 689.88%367.86M | 1,008.99%567.79M |
| Less:Minority Profit | -2.66%106.79M | -12.19%93.37M | -18.05%46.24M | 4.60%95.28M | 15.90%109.71M | 17.78%106.33M | 29.30%56.43M | 16.01%91.09M | 10.27%94.66M | 2.25%90.27M |
| Net profit of parent company owners | 205.14%519.77M | 172.62%333.02M | 601.27%194.12M | 9.69%233.15M | -37.65%170.34M | -74.42%122.16M | -89.34%27.68M | 163.91%212.54M | 284.33%273.2M | 416.76%477.52M |
| Earning per share | ||||||||||
| Basic earning per share | 200.00%0.18 | 175.00%0.11 | 598.94%0.0657 | 14.29%0.08 | -33.33%0.06 | -75.00%0.04 | -89.32%0.0094 | 163.64%0.07 | 280.00%0.09 | 420.00%0.16 |
| Diluted earning per share | 200.00%0.18 | 175.00%0.11 | 598.94%0.0657 | 14.29%0.08 | -33.33%0.06 | -75.00%0.04 | -89.32%0.0094 | 163.64%0.07 | 280.00%0.09 | 420.00%0.16 |
| Other composite income | 528.35%119.34M | 36,594.09%138.4M | -89.75%-26.84M | 338.69%99.57M | 141.80%18.99M | 100.78%377.18K | 14.63%-14.15M | -699.98%-41.72M | -669.89%-45.44M | -1,433.35%-48.18M |
| Other composite income of parent company owners | 654.50%119.65M | 7,967.57%136.02M | -82.07%-27.98M | 330.38%95.17M | 134.58%15.86M | 96.39%-1.73M | 7.96%-15.37M | -552.20%-41.31M | -555.76%-45.86M | -1,150.78%-47.92M |
| Other composite income of minority owners | -109.90%-310.19K | 13.18%2.38M | -6.67%1.14M | 1,182.33%4.4M | 638.46%3.13M | 906.25%2.11M | 837.50%1.22M | 81.35%-406.91K | 120.31%424.47K | 72.41%-261.21K |
| Total composite income | 149.43%745.91M | 146.78%564.79M | 205.19%213.52M | 63.41%428M | -7.25%299.04M | -55.96%228.86M | -75.61%69.96M | 205.99%261.92M | 692.81%322.42M | 982.93%519.61M |
| Total composite income of parent company owners | 243.41%639.43M | 289.48%469.04M | 1,249.46%166.13M | 91.73%328.32M | -18.10%186.2M | -71.97%120.43M | -94.93%12.31M | 152.94%171.24M | 264.56%227.33M | 393.86%429.6M |
| Total composite income of minority owners | -5.64%106.48M | -11.69%95.75M | -17.80%47.39M | 9.92%99.68M | 18.67%112.85M | 20.47%108.43M | 31.71%57.65M | 18.79%90.68M | 13.53%95.09M | 3.06%90.01M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.